Charles River Laboratories (Netherlands)

Recent papers from Charles River Laboratories (Netherlands)

1. Synchrotron-Generated X-Ray Microbeam Irradiation Enhances Hippocampal Neurogenesis in Healthy RatsRadiation Research · 2026
2. Asticcacaulis aquihabitans sp. nov., a novel psychrotrophic member of the phylum Pseudomonadota isolated from Lake Michigan potable waterINTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY · 2026
3. Scientific perspectives on in vivo developmental neurotoxicity testing: study design, regulatory context, and future directionsArchives of Toxicology · 2026
4. Preclinical Safety Evaluation of Human Lactoferrin Alpha (Effera ® )International Journal of Toxicology · 2026
5. Efficacy and Safety of Satralizumab for Thyroid Eye Disease: Week 24 Results from the Phase 3 SatraGO-1 and SatraGO-2 Randomized TrialsOphthalmology · 2026
6. Wnt Pathway Agonism as a Therapeutic Strategy for Retinal Vascular Diseases: A Narrative Review of Evidence to DateOphthalmology and Therapy · 2026
7. Polyaromatic hydrocarbon driven developmental toxicity is dependent on the aryl hydrocarbon receptor: A case study with benzo(a)pyreneRegulatory Toxicology and Pharmacology · 2026
8. Maxillomandibular advancement for obstructive sleep apnea: a contemporary reviewFrontiers in Surgery · 2026
9. Enumeration of Microscopic Ovarian Structures in Rodents: Best Practices and Toxicological SignificanceBirth Defects Research · 2026
10. Automating CAR T cell Manufacturing Across Distinct Platforms Delivers Similar Cell Quality, Phenotype, and Function.Cytotherapy · 2026
11. Assay-dependent Artifactual Prolongation of Activated Partial Thromboplastin Time (aPTT) in Cynomolgus Monkeys: Potential Role of POEGMAInternational Journal of Toxicology · 2026
12. FELASA’s accreditation for high-quality training in laboratory animal sciencesLaboratory Animals · 2026
13. Timing matters: Exon skipping therapy is most effective when initiated early in a mouse model of Duchenne muscular dystrophyMolecular Therapy — Nucleic Acids · 2026
14. Early bone-formation response to sclerostin antibody is altered by prior antiresorptive treatment in ovariectomized ratsJBMR Plus · 2026
15. Latin American consensus on the medical oncologic management of early-stage HR+/HER2− breast cancer: Addressing regional disparities in Spanish-speaking countriesThe Breast · 2026
16. Structure–Activity Relationship Studies Resulting in the Identification of Potent and Selective Salt-Inducible Kinase InhibitorsACS Medicinal Chemistry Letters · 2026
17. Comparative assessment of tissue cross-reactivity and pharmacokinetic half-life of malaria monoclonal antibodiesFrontiers in Immunology · 2026
18. Quantifying Transporter Activity: An Absolute Scaling Approach Using DigoxinMolecular Pharmaceutics · 2026
19. Expanding access to urban nature: Floating gardens as equitable and inclusive blue-green infrastructure in the Chicago RiverCommunity Development · 2026
20. 18 th GCC Closed Forum: Compliance with FDA Biomarkers Guidance, Novel ELN/LIMS Platforms, Sample Reconciliation, Emerging Technologies, Improvements in ELISpot, Post-extraction Sample Stability, LBA Singlicate, Regulatory Inspections, Chicken anti-Human IgG, Cross-validation HarmonizationBioanalysis · 2026